1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Herbert, A.P.
Deakin, J.A.
Schmidt, C.Q.
Blaum, B.S.
Egan, C.
Ferreira, V.P.
Pangburn, M.K.
Lyon, M.
Uhrin, D.
Barlow, P.N.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J. Biol. Chem.
JBCHA3
0071
0021-9258
282
18960
18968
10.1074/jbc.M609636200
17360715
Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism.
2007
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7010.091
COMPLEMENT FACTOR H
CCP MODULE 7, RESIDUES 386-446
YES
1
man
polymer
H FACTOR 1
no
no
LRKCYFPYLENGYNQNYGRKFVQGKSIDVACHPGYALPKAQTTVTCMENGWSPTPRCIRVK
LRKCYFPYLENGYNQNYGRKFVQGKSIDVACHPGYALPKAQTTVTCMENGWSPTPRCIRVK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
9606
HOMO SAPIENS
4922
PICHIA PASTORIS
KM71H
PPICZALPHAB
citation
pdbx_nmr_spectrometer
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
1
0
2007-03-20
1
1
2011-05-08
1
2
2011-07-13
1
3
2018-05-02
_citation.journal_abbrev
_citation.page_last
_citation.pdbx_database_id_DOI
_citation.title
_pdbx_nmr_spectrometer.model
C3D AND HEPARIN BINDING COMPLEMENT FACTOR H DOMAINS SCR19-20
FOUR MODELS OF HUMAN FACTOR H DETERMINED BY SOLUTION SCATTERING CURVE-FITTING AND HOMOLOGY MODELLING
FACTOR H, 15TH AND 16TH C-MODULE PAIR ( NMR, MINIMIZED AVERAGED STRUCTURE)
FACTOR H, 15TH C-MODULE PAIR (NMR, MINIMIZED AVERAGED STRUCTURE)
HOMOLOGY MODEL OF HUMAN FACTOR H SCRS 6 AND 7
SOLUTION STRUCTURE OF THE PRIMARY HOST RECOGNITION REGION OF COMPLEMENT FACTOR H
STRUCTURE OF HUMAN COMPLEMENT FACTOR H CARBOXYL TERMINALDOMAINS 19-20: A BASIS FOR ATYPICAL HEMOLYTIC UREMICSYNDROME
STRUCTURE OF CCP MODULE 7 OF COMPLEMENT FACTOR H - THE AMD AT RISK VARIENT (402H)
PDBE
Y
PDBE
2007-02-16
REL
ENGINEERED RESIDUE IN CHAIN A, HIS 402 TO TYR
PROTEIN SEGMENT CONTAINING THE COMMON TYR VARIENT AT
POSITION 402
THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY ON 13C, 15N-LABELED FACTOR H CCP MODULE 7 (402Y)
LOWEST OVERALL ENERGY
50
20
CBCANH
H_CCONH TOCSY
HNCO
15N EDITED TOCSY HSQC
13C EDITED NOESY HSQC
15N EDITED NOESY HSQC
HCCH TOCSY
HBCBCGCDCEHE
HBCBCGCDHD
C_CCONH TOCSY
20
mM
5.2
pH
1.0
atm
298.0
K
20
mM
5.2
pH
1.0
atm
298.0
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
ARIA 2.0
1
10% WATER/90% D2O
BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE,SIMONSON,WARREN
refinement
CNS
1.1
structure solution
CCPNMR ANALYSIS
ANALYSIS
600
Bruker
Avance
800
Bruker
Avance
LEU
386
n
1
LEU
386
A
ARG
387
n
2
ARG
387
A
LYS
388
n
3
LYS
388
A
CYS
389
n
4
CYS
389
A
TYR
390
n
5
TYR
390
A
PHE
391
n
6
PHE
391
A
PRO
392
n
7
PRO
392
A
TYR
393
n
8
TYR
393
A
LEU
394
n
9
LEU
394
A
GLU
395
n
10
GLU
395
A
ASN
396
n
11
ASN
396
A
GLY
397
n
12
GLY
397
A
TYR
398
n
13
TYR
398
A
ASN
399
n
14
ASN
399
A
GLN
400
n
15
GLN
400
A
ASN
401
n
16
ASN
401
A
TYR
402
n
17
TYR
402
A
GLY
403
n
18
GLY
403
A
ARG
404
n
19
ARG
404
A
LYS
405
n
20
LYS
405
A
PHE
406
n
21
PHE
406
A
VAL
407
n
22
VAL
407
A
GLN
408
n
23
GLN
408
A
GLY
409
n
24
GLY
409
A
LYS
410
n
25
LYS
410
A
SER
411
n
26
SER
411
A
ILE
412
n
27
ILE
412
A
ASP
413
n
28
ASP
413
A
VAL
414
n
29
VAL
414
A
ALA
415
n
30
ALA
415
A
CYS
416
n
31
CYS
416
A
HIS
417
n
32
HIS
417
A
PRO
418
n
33
PRO
418
A
GLY
419
n
34
GLY
419
A
TYR
420
n
35
TYR
420
A
ALA
421
n
36
ALA
421
A
LEU
422
n
37
LEU
422
A
PRO
423
n
38
PRO
423
A
LYS
424
n
39
LYS
424
A
ALA
425
n
40
ALA
425
A
GLN
426
n
41
GLN
426
A
THR
427
n
42
THR
427
A
THR
428
n
43
THR
428
A
VAL
429
n
44
VAL
429
A
THR
430
n
45
THR
430
A
CYS
431
n
46
CYS
431
A
MET
432
n
47
MET
432
A
GLU
433
n
48
GLU
433
A
ASN
434
n
49
ASN
434
A
GLY
435
n
50
GLY
435
A
TRP
436
n
51
TRP
436
A
SER
437
n
52
SER
437
A
PRO
438
n
53
PRO
438
A
THR
439
n
54
THR
439
A
PRO
440
n
55
PRO
440
A
ARG
441
n
56
ARG
441
A
CYS
442
n
57
CYS
442
A
ILE
443
n
58
ILE
443
A
ARG
444
n
59
ARG
444
A
VAL
445
n
60
VAL
445
A
LYS
446
n
61
LYS
446
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
CYS
389
A
N
CYS
4
A
O
PHE
406
A
O
PHE
21
A
N
ILE
412
A
N
ILE
27
A
O
VAL
429
A
O
VAL
44
A
N
ALA
421
A
N
ALA
36
A
O
ILE
443
A
O
ILE
58
1
A
A
HG3
HA
GLN
MET
408
432
1.16
2
A
A
HB2
HG
MET
SER
432
437
1.34
5
A
A
H
HG21
ASP
THR
413
428
1.05
6
A
A
HG3
HB3
ARG
GLN
387
408
1.12
6
A
A
HG3
HA
GLN
MET
408
432
1.34
7
A
A
O
H
LYS
CYS
410
431
1.58
9
A
A
HG3
HA
GLN
MET
408
432
1.29
11
A
A
HG3
HA
GLN
MET
408
432
1.10
11
A
A
HD3
HA
ARG
ASN
387
434
1.31
14
A
A
HG2
HB3
ARG
GLN
387
408
1.29
15
A
A
HG3
HA
GLN
MET
408
432
1.31
16
A
A
HG3
HB3
ARG
GLN
387
408
0.96
17
A
A
HG3
HA
GLN
MET
408
432
1.16
19
A
A
HG3
HA
GLN
MET
408
432
1.25
1
A
GLU
433
34.46
46.03
1
A
ASN
434
71.97
-24.14
1
A
TRP
436
40.56
111.34
1
A
THR
439
71.88
116.05
1
A
ARG
441
-147.65
-14.78
1
A
CYS
442
56.63
83.34
2
A
LEU
394
-81.96
-96.16
2
A
GLU
395
173.79
-33.36
2
A
ASN
396
-145.07
38.75
2
A
ASN
434
69.18
-20.94
2
A
TRP
436
35.69
106.81
2
A
THR
439
72.60
113.45
2
A
PRO
440
-68.62
94.12
3
A
GLU
395
59.97
-84.13
3
A
ILE
412
177.72
132.71
3
A
ASP
413
-125.71
-89.46
3
A
VAL
414
34.74
75.32
3
A
ALA
415
-176.06
52.06
3
A
THR
427
-140.93
20.30
3
A
MET
432
-107.39
-140.13
3
A
ASN
434
78.43
-11.43
3
A
THR
439
72.66
117.65
3
A
PRO
440
-64.44
93.81
3
A
CYS
442
-63.07
98.89
4
A
ASN
399
-77.77
44.49
4
A
ASN
434
67.90
-16.51
4
A
TRP
436
58.31
148.15
4
A
THR
439
71.71
111.08
5
A
ARG
387
-66.73
-170.89
5
A
ILE
412
173.44
134.04
5
A
ASP
413
-130.97
-140.79
5
A
THR
427
-141.62
12.86
5
A
GLU
433
28.54
43.09
5
A
ASN
434
65.13
-17.76
5
A
TRP
436
42.55
111.22
5
A
THR
439
76.01
131.16
6
A
ARG
387
48.52
-172.15
6
A
LYS
388
73.39
37.55
6
A
ASN
399
-80.58
49.30
6
A
PRO
418
-34.40
120.71
6
A
ALA
421
-175.75
-170.57
6
A
GLU
433
-37.49
76.97
6
A
TRP
436
-37.87
113.56
6
A
THR
439
70.99
112.81
6
A
PRO
440
-66.46
86.08
7
A
GLU
395
66.49
-71.67
7
A
ASN
399
-105.68
59.26
7
A
PRO
418
-54.90
105.92
7
A
GLU
433
39.09
40.32
7
A
ASN
434
70.33
-24.05
7
A
TRP
436
56.35
128.78
7
A
THR
439
73.74
121.61
7
A
PRO
440
-66.60
94.64
8
A
ILE
412
-170.02
130.39
8
A
ASN
434
72.66
-24.95
8
A
TRP
436
36.25
105.41
8
A
THR
439
71.95
121.90
8
A
ARG
441
-131.38
-45.77
8
A
CYS
442
64.78
91.97
9
A
PRO
418
-58.05
103.07
9
A
ASN
434
73.02
-16.33
9
A
TRP
436
35.21
106.20
9
A
THR
439
72.94
119.37
9
A
ARG
444
-175.35
-154.64
10
A
ARG
387
-59.42
174.98
10
A
LYS
388
-166.97
65.32
10
A
CYS
389
-50.84
108.80
10
A
PRO
418
-53.77
108.71
10
A
TRP
436
36.42
101.42
10
A
THR
439
74.35
114.19
10
A
PRO
440
-68.78
95.95
11
A
PRO
418
-45.21
106.98
11
A
GLU
433
-32.98
88.55
11
A
TRP
436
-38.93
117.89
11
A
THR
439
71.61
109.53
11
A
PRO
440
-69.42
98.31
12
A
ARG
387
-109.45
-156.41
12
A
LYS
388
-164.61
88.63
12
A
ASN
434
76.03
-27.71
12
A
TRP
436
35.99
106.44
12
A
THR
439
72.80
116.33
12
A
ARG
441
-147.20
-17.65
12
A
CYS
442
58.10
87.07
13
A
ILE
412
-170.80
127.51
13
A
PRO
418
-32.32
112.44
13
A
ASN
434
68.89
-24.57
13
A
TRP
436
59.45
128.87
13
A
THR
439
74.39
123.30
13
A
PRO
440
-62.99
93.35
13
A
VAL
445
-106.35
45.82
14
A
ARG
387
55.53
-169.11
14
A
GLU
395
67.59
-69.54
14
A
CYS
416
-100.77
-169.25
14
A
ASN
434
78.77
-9.49
14
A
TRP
436
-12.55
114.00
14
A
THR
439
71.17
121.27
15
A
GLU
395
57.14
-89.93
15
A
ASN
399
39.54
54.62
15
A
PRO
418
-59.83
108.53
15
A
ASN
434
70.22
-23.60
15
A
TRP
436
56.04
125.72
15
A
THR
439
68.98
109.30
15
A
PRO
440
-55.14
102.41
16
A
ARG
387
-44.70
-174.29
16
A
LYS
388
73.98
79.17
16
A
ASN
399
-81.12
48.04
16
A
GLU
433
28.47
68.09
16
A
THR
439
73.71
112.00
17
A
GLU
433
28.78
52.74
17
A
ASN
434
76.29
-25.18
17
A
TRP
436
20.39
106.33
17
A
THR
439
73.42
116.64
18
A
PRO
392
-68.89
-90.45
18
A
TYR
393
167.52
128.76
18
A
LEU
394
-73.40
-131.97
18
A
GLU
395
-155.63
-40.99
18
A
GLU
433
37.91
42.84
18
A
ASN
434
71.24
-20.62
18
A
TRP
436
24.72
107.43
18
A
THR
439
73.61
118.46
19
A
PRO
418
-53.83
107.60
19
A
ASN
434
69.56
-19.80
19
A
TRP
436
52.73
124.49
19
A
THR
439
74.15
113.41
19
A
ARG
441
-154.13
-39.28
19
A
CYS
442
60.47
89.90
20
A
GLU
433
34.65
40.68
20
A
ASN
434
76.67
-23.85
20
A
TRP
436
-39.64
125.09
20
A
THR
439
72.76
116.49
20
A
PRO
440
-64.32
92.15
20
A
CYS
442
60.00
81.39
COMPLEMENT FACTOR H
Structure of CCP module 7 of complement factor H - The AMD Not at risk varient (402Y)
1
N
N
A
LEU
422
A
LEU
37
HELX_P
A
GLN
426
A
GLN
41
5
1
5
disulf
2.032
A
CYS
389
A
SG
CYS
4
1_555
A
CYS
431
A
SG
CYS
46
1_555
disulf
2.030
A
CYS
416
A
SG
CYS
31
1_555
A
CYS
442
A
SG
CYS
57
1_555
IMMUNE RESPONSE
AGE RELATED MACULAR DEGENERATION, AGE-RELATED MACULAR DEGENERATION, DISEASE MUTATION, GLYCOSAMINOGLYCAN, ALTERNATIVE SPLICING, COMPLEMENT ALTERNATE PATHWAY, GLYCOPROTEIN, INNATE IMMUNITY, IMMUNE RESPONSE, SUSHI, FACTOR H, COMPLEMENT, POLYMORPHISM
CFAH_HUMAN
UNP
1
P08603
386
446
2JGX
386
446
P08603
A
1
1
61
1
HIS
engineered mutation
TYR
402
2JGX
A
P08603
UNP
402
17
2
2
2
anti-parallel
anti-parallel
anti-parallel
A
LYS
388
A
LYS
3
A
TYR
390
A
TYR
5
A
LYS
405
A
LYS
20
A
VAL
407
A
VAL
22
A
LYS
410
A
LYS
25
A
ASP
413
A
ASP
28
A
THR
428
A
THR
43
A
CYS
431
A
CYS
46
A
TYR
420
A
TYR
35
A
ALA
421
A
ALA
36
A
ILE
443
A
ILE
58
A
ARG
444
A
ARG
59
1
P 1